tradingkey.logo
tradingkey.logo
Search

MapLight Therapeutics Inc

MPLT
Add to Watchlist
13.020USD
-1.010-7.20%
Close 07-31 16:00ETQuotes delayed by 15 min
590.40MMarket Cap
LossP/E TTM

MPLT Financials

See MapLight Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

MapLight Therapeutics Inc Earnings Date

Latest Release
May 17, 2026
EPS / Forecast
-1.34/-1.09
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-18.56
-891.37%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q2
Financial Indicators
EPS
---1.34
----
----
Net Profit
---60.67M
---79.55M
----
Operating profit
---64.50M
---83.38M
----
Net Profit
---60.67M
---79.55M
----
Current assets
--327.23M
--324.67M
--73.20M
Total current liabilities
--14.28M
--16.23M
--14.98M
Total assets
--418.79M
--479.51M
--84.12M
Total liabilities
--18.95M
--21.14M
--20.36M
Total equity
--399.83M
--458.37M
--63.76M
Net operating income
---51.18M
----
----
Net investment
--67.01M
----
----
Net financing
---6.85M
----
----

FAQs

What are the current assets of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its current assets were 324.67M, with a year-on-year change of 183.30.

What are the total assets of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its total assets of MapLight Therapeutics Inc were 479.51M, with a year-on-year change of 250.22.

What are the total liabilities of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its total liabilities of MapLight Therapeutics Inc were 21.14M, with a year-on-year change of -2.67.

What is the total equity of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its total equity of MapLight Therapeutics Inc was 458.37M, with a year-on-year change of 297.91.

What is the net operating income of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its net operating income of MapLight Therapeutics Inc was -169.08M, with a year-on-year change of -103.85.

What is the net investment of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its net investment of MapLight Therapeutics Inc was -323.21M, with a year-on-year change of -300.07.

What is the net financing of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its net financing of MapLight Therapeutics Inc was 469.82M, with a year-on-year change of 297.95.

What is the Earnings Per Share (EPS) of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -18.56, with a year-on-year change of -891.37.

What is the net income of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its net income was -161.15M, with a year-on-year change of -107.72.

What is the Return on Assets (ROA) of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -52.29, with a year-on-year change of 23.06.

What is the operating profit of MapLight Therapeutics Inc?

According to MapLight Therapeutics Inc's FY2025 earnings report, its operating profit was -169.08M, with a year-on-year change of -103.85.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.